Skip to content

Dianthus Therapeutics

US · DNTH #2155 by market cap Listed 1970
84.55 -0.28 -0.33%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:59

Recent news

  • Dianthus Therapeutics(DNTH.US) Officer Sells US$11.23 Million in Common Stock
    Market Newswire · 2026/11/13
  • Rating change
    Roth MKM Maintains Dianthus Therapeutics(DNTH.US) With Buy Rating, Maintains Target Price $113
    Market Newswire · 2026/10/27
  • Rating change
    Jefferies Maintains Dianthus Therapeutics(DNTH.US) With Buy Rating, Maintains Target Price $132
    Market Newswire · 2026/6/15
  • Rating change
    A Quick Look at Today's Ratings for Dianthus Therapeutics(DNTH.US), With a Forecast Between $122 to $150
    Market Newswire · 2026/8/5
  • Rating change
    Raymond James Maintains Dianthus Therapeutics(DNTH.US) With Buy Rating
    Market Newswire · 2026/6/13
  • Rating change
    J.P. Morgan Initiates Dianthus Therapeutics(DNTH.US) With Buy Rating, Announces Target Price $135
    Market Newswire · 2026/9/11
  • H.C. Wainwright Maintains Dianthus Therapeutics(DNTH.US) With Buy Rating, Maintains Target Price $158
    Market Newswire · 2026/11/7
  • Rating change
    Truist Financial Maintains Dianthus Therapeutics(DNTH.US) With Buy Rating
    Market Newswire · 2026/6/15
  • Wells Fargo Maintains Dianthus Therapeutics(DNTH.US) With Buy Rating, Maintains Target Price $135
    Market Newswire · 2026/11/5
  • Rating change
    Wedbush Maintains Dianthus Therapeutics(DNTH.US) With Buy Rating, Maintains Target Price $105
    Market Newswire · 2026/6/15
  • A Quick Look at Today's Ratings for Dianthus Therapeutics(DNTH.US), With a Forecast Between $122 to $135
    Market Newswire · 2026/11/6
  • Rating change
    Evercore Maintains Dianthus Therapeutics(DNTH.US) With Buy Rating, Raises Target Price to $134
    Market Newswire · 2026/8/10
  • Rating change
    Citi Initiates Dianthus Therapeutics(DNTH.US) With Buy Rating, Announces Target Price $156
    Market Newswire · 2026/9/4
  • Rating change
    William Blair Maintains Dianthus Therapeutics(DNTH.US) With Buy Rating
    Market Newswire · 2026/9/18
  • Rating change
    A Quick Look at Today's Ratings for Dianthus Therapeutics(DNTH.US), With a Forecast Between $122 to $200
    Market Newswire · 2026/8/6
  • Rating change
    J.P. Morgan Maintains Dianthus Therapeutics(DNTH.US) With Buy Rating
    Market Newswire · 2026/9/24
  • Rating change
    Truist Financial Maintains Dianthus Therapeutics(DNTH.US) With Buy Rating, Announces Target Price $128
    Market Newswire · 2026/8/6
  • Rating change
    Roth MKM Initiates Dianthus Therapeutics(DNTH.US) With Buy Rating, Announces Target Price $113
    Market Newswire · 2026/10/27
  • Rating change
    LifeSci Capital Maintains Dianthus Therapeutics(DNTH.US) With Buy Rating, Maintains Target Price $125
    Market Newswire · 2026/9/30
  • Stifel Maintains Dianthus Therapeutics(DNTH.US) With Buy Rating, Maintains Target Price $133
    Market Newswire · 2026/11/13
  • Rating change
    H.C. Wainwright Maintains Dianthus Therapeutics(DNTH.US) With Buy Rating, Maintains Target Price $130
    Market Newswire · 2026/6/12
  • Rating change
    Stifel Maintains Dianthus Therapeutics(DNTH.US) With Buy Rating, Maintains Target Price $133
    Market Newswire · 2026/8/14
  • Rating change
    Wells Fargo Maintains Dianthus Therapeutics(DNTH.US) With Buy Rating, Maintains Target Price $135
    Market Newswire · 2026/6/17
  • Rating change
    Wedbush Maintains Dianthus Therapeutics(DNTH.US) With Buy Rating, Raises Target Price to $105
    Market Newswire · 2026/6/12
  • H.C. Wainwright Maintains Dianthus Therapeutics(DNTH.US) With Buy Rating, Maintains Target Price $158
    Market Newswire · 2026/10/16

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 19:59:44 · For reference only, not investment advice and not tailored to your situation.

Dianthus Therapeutics discussion 0 comments

Add a comment